Graduate College of Biomedical Sciences
Engineer Degree 1971
Ecole Polytechnique Paris, France Master Degree in Biochemistry 1972
University Paris VII Paris, France PhD Biochemistry (cum laude) 1977
University Paris VII Paris, France
1978-80 Postdoctoral Research Assoc UCI & CNRS Fellow
1972-73 Stagiaire de Recherches, National Center for Scientific Research (CNRS)
1973-76 Attache de Recherches CNRS
1976-78 Charge de Recherches CNRS
1/81-6/81 Assist. Research Psychobiologist UCI
7/81-6/82 Assist. Research Psychobiologist & Adjunct Lecturer UCI
6/82-6/84 Assist. Professor-in-Residence UCI
7/84-6/89 Assoc. Professor-in-Residence UCI
9/88-6/89 Visiting Scientist, Genentech Inc., South San Francisco, CA
1989-1993 Associate Professor, University of Southern California
Dept. of Biology - Section of Neurobiology
1993-2011 Professor, USC, Dept. of Biology-Section of Neurobiology, Department of Neurology, USC Medical School, Department of Biomedical Engineering, USC.
2001- 2003: Visiting Professor, Department of Psychiatry & Human Behavior, UCI, CA
2001-2003: VP Research, Tensor Biosciences, Irvine, CA
2012- Professor and Dean, Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA
UCI: Psychobiology: 1984-1987.
USC: BISC306: Human Physiology BISC 421: Neurobiology BISC 524: Neuroscience BISC221: Advanced General Biology Special Topics in Neuroscience BISC104: Introduction to Physiology for non-biology majors BISC230Lg: Brain, Mind and Machines: Topics in Neuroscience
Mechanisms implicated in long-term synaptic potentiation and depression in hippocampus and other brain regions. Regulation of glutamate receptors. Role of oxygen free radicals in central nervous system. Mechanisms underlying selective neuronal degeneration. Computational neuroscience
Current Research Support:
- PI: NINDS (R01): “Simulation of learning: models and biological validation”. 02/02/09-01/31/2013.
- Co-Investigator: NINDS (P01): “BDNF and Spine-Related Disorders of Memory and Cognition”. (PI: Dr. Christine Gall). 09/01/09-08/31/2016.
- PI: NeuralStem. “Efficacy of NSI cell implantation to the limbic system following the development of chronic mTLE in the rat”. 03/01/2012-02/28/2013.
Pfizer Lecture, Institut de Recherches Cliniques de Montreal. Canada, December 1984.
Doctor Honoris Causa, University of Provence, Marseille, France, 2010.
USC Mellon Excellence Award for mentoring graduate students, April 2010.
American Neuroscience Society
International Society of Neurochemistry
ISI Highly Cited Researchers
Fellow of the World Innovation Foundation
Panel member: NSF " Molecular and Cellular Neurobiology ", 1983-1985.
Panel Member: NIH: NSD-B Study Section, 2005-2009.
Panel Member: NIH-Fogarty International, 2008-present.
Panel Member: NIH: F02 Review Panel, 2008-present.
Lynch, G. and Baudry, M. The biochemistry of memory: A new and specific hypothesis. Science. 224: 1057-1063, 1984. Morris, R.G.M., Anderson, E., Lynch, G.S. and Baudry, M. Selective impairment of learning and blockade of long-term potentiation by N-methyl-D-aspartate receptor antagonist, AP-5. Nature 319: 774-776, 1986. Massicotte, G., Vanderklish, P., Lynch, G., and Baudry, M. Modulation of AMPA/quisqualate receptors by phospholipase A2: A necessary step in long-term potentiation? Proc. Nat. Acad. Sci.(USA) 88: 1893-1897, 1991. Bruce, A., Malfroy, B. and Baudry, M. ß-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic oxygen free radical scavenger. Proc. Nat. Acad. Sci. 93: 2312-2316, 1996. Musleh, W., Bi, X., Tocco, G., Yaghoubi, S. and Baudry, M. Glycine-induced long-term potentiation is associated with structural and functional modifications of AMPA receptors. Proc. Nat. Acad. Sci. 94: 9451-9456, 1997. Rong, Y., Tocco, G., Doctrow, S. and Baudry, M. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc. Nat. Acad. Sci. 96: 9897-9902, 1999. Bi, R., Broutman, G., Foy, M., Thompson, R.F. and Baudry, M. The tyrosine kinase and MAP kinase pathways mediate multiple effects of estrogen in hippocampus. Proc. Nat. Acad. Sci. 97: 3602-3607, 2000. Bi, R., Foy, M. R., Vouimba, R.-M., Thompson, R.F. and Baudry, M. Cyclic changes in estrogen regulate synaptic plasticity through the MAP kinase pathway. Proc. Nat. Acad. Sci. 98: 13391:13395, 2001.
Liu, R., Liu, Y., Bi, X., Thompson, R.F., Doctrow, S.R., Malfroy, B. and Baudry, M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase.catalase mimetics. Proc. Nat. Acad. Sci. 100: 8527-8531, 2003.
Zhou, M. and Baudry, M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26: 2956-2963, 2006.
Xu, W., Wong, T.P., Chery, N., Gaertner, T., Wang, Y.T.and Baudry,M. Calpain-mediated truncation of mGluR1a: a key step in excitotoxicity. Neuron, 53: 399-412, 2007.
Dominguez, R., Hu, E., Zhou, M. and Baudry, M. 17ß-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and ß-arrestin-1. J. Neurosci. 29: 4228-4238, 2009.
Jourdi, H., Hsu, Y.-T., Zhou, M., Qin, Q., Bi, X. and Baudry, M. Positive AMPA receptor modulation rapidly stimulates dendritic mRNA translation through BDNF release. J. Neurosci. 29: 8688-8697, 2009.
Zadran, S., Jourdi, H., Rostamiani, K., Qin, Q., Bi, X. and Baudry, M. BDNF- and EGF-mediated neuronal calpain activation through MAPK-dependent phosphorylation. J. Neurosci. 30: 1086-1095, 2010.
Zadran, S., Qin, Q., Bi, X., Zadran, H., Kim, Y., Foy, M.R., Thompson, R.F., and Baudry, M. 17-ß-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc. Nat. Acad. Sci. USA 106: 21936-21941, 2009.
Baudry, M., Bi, X., Gall, C. and Lynch, G. The biochemistry of memory: the 26-year journey of a new and specific hypothesis. Neurobiol. Learning & Memory 95: 125-133, 2011.
Clausen, A., Xu, X., Bi, X. and Baudry, M. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer’s disease: Protection against and interruption of progression of amyloid and tau pathology and cognitive decline. J. Alz. Dis. (in press).